Article

Steve Melnick, Answers How ACOs Will Impact the Pharmacy Benefit and Medical Costs

Steve Melnick, President, SM Innovations, says that accountable care organizations (ACOs) will impact the pharmacy benefit by moving the healthcare system from a volume-based to a value-based model.

Steve Melnick, President, SM Innovations, says that accountable care organizations (ACOs) will impact the pharmacy benefit by moving the healthcare system from a volume-based to a value-based model. By moving to a value-based model, pharmacies will need to build long-term relations with patients and understand how the whole population is managing. Mr Melnick notes that it might be too early to tell if ACOs will impact cost and quality, but there will continue to be funding for experimentation and development.

"Ultimately what we'd like to see are models that improve cost, improve quality, and improve patient satisfaction," said Melnick.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Ibrahim Aldoss
Dr Pankit Vachhani
Mansi Shah, MD
Dr John Mascarenhas
CK Wang, MD, COTA
Dr Pankit Vachhani
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Merrill H. Stewart, MD
Dr John Mascarenhas
Carla Nester, MD, MSA, FASN, Stead Family Children's Hospital
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo